Dr. Jeff Duan is recognized as one of the top pharmacologists in China. Dr. Duan has leadership experience in developing pharmacology studies in Oncology ,Inflammation, and Auto-immune Diseases.

He has validated animal models using strains bred and raised in China, against the American and European strains. Formerly of Hutchison Medipharma, he was instrumental in securing multi-national collaborations. Dr. Duan is a standing Council Member of the Shanghai Experimental Animal Commission.

Dr. Webster Jee is legendary in pioneering the preclinical models for osteoporosis. He was instrumental in developing industry standards in histomorphometry for assessment of bone metabolism. Over his 50 year scientific career, Dr. Jee has been a highly respected consultant to and helped multiple international companies to develop blockbuster drugs for bone diseases such as Procter & Gamble Pharmaceuticals, Eli Lilly, Pfizer etc.

Dr. Darren Ji brings profound international business and management experiences in pharmaceuticals/biotech development. In his business career with Procter & Gamble, Dr. Ji engineered a number of significant M&A opportunities between P&G and bioscience entities in the East Asia region. Two of the deals were singled out by Yahoo Finance as “outstanding activities” for P&G in 2007. Dr. Ji also has experience as a pharmaceutical project leader and managed multiple pharmaceutical R&D partnerships in the US, Europe and Asia.

Dr. Mei-Shu Shih is a premier research veterinary pathologist, and widely regarded as one of the best service scientists in the Bone and Orthopaedic fields. Dr. Shih has held leadership positions in academic laboratories, biotech companies and CROs with specialty focus in osteoporosis, fracture healing, orthopaedics & tissue engineering. Dr. Shih brings extensive experience in compliant scientific services.

Dr. Ray Takigiku is a pharmaceutical executive who at Procter & Gamble Pharmaceuticals developed world class R&D functions in Discovery, Development and Market Support, and was in the leadership team behind the development of the blockbuster osteoporosis drug Actonel. Dr. Takigiku has extensive regulatory experience and brings the highest international standards for our QA organization and cGLP systems.